PEN vs ISRG

For growth investors, Intuitive Surgical, Inc.

(ISRG) is the stronger pick with 20. 5% revenue growth year-over-year, versus 17. 5% for Penumbra, Inc. (PEN). Intuitive Surgical, Inc. (ISRG) offers the better valuation at 57. 2x trailing P/E (43. 3x forward), making it the more compelling value choice. Analysts rate Intuitive Surgical, Inc. (ISRG) a "Buy" — based on 55 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Intuitive Surgical, Inc.

(ISRG) is the cheapest at 57. 2x versus Penumbra, Inc. at 71. 3x. On forward P/E, Intuitive Surgical, Inc. is actually cheaper at 43. 3x.

Over the past 5 years, Intuitive Surgical, Inc.

(ISRG) delivered a total return of +61. 7%, compared to +22. 3% for Penumbra, Inc. (PEN). Over 10 years, the gap is even starker: ISRG returned +549. 2% versus PEN's +501. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Penumbra, Inc.

(PEN) is the lower-risk stock at 0. 23β versus Intuitive Surgical, Inc. 's 1. 00β — meaning ISRG is approximately 336% more volatile than PEN relative to the S&P 500. On balance sheet safety, Intuitive Surgical, Inc. (ISRG) carries a lower debt/equity ratio of 2% versus 15% for Penumbra, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Intuitive Surgical, Inc.

(ISRG) is pulling ahead at 20. 5% versus 17. 5% for Penumbra, Inc. (PEN). On earnings-per-share growth, the picture is similar: Penumbra, Inc. grew EPS 1156% year-over-year, compared to 22. 6% for Intuitive Surgical, Inc.. Over a 3-year CAGR, PEN leads at 18. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Intuitive Surgical, Inc.

(ISRG) is the more profitable company, earning 28. 4% net margin versus 12. 7% for Penumbra, Inc. — meaning it keeps 28. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ISRG leads at 29. 3% versus 13. 5% for PEN. At the gross margin level — before operating expenses — PEN leads at 67. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Intuitive Surgical, Inc.

(ISRG) trades at 43. 3x forward P/E versus 65. 8x for Penumbra, Inc. — 22. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ISRG: 38. 3% to $622. 60.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Penumbra, Inc.

(PEN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 23), +501. 4% 10Y return). Both have compounded well over 10 years (PEN: +501. 4%, ISRG: +549. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.